Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society

Provides uniform definition of cardiac target volumes

Advice on patient selection for stereotactic arrhythmia radioablation (STAR), including aetiology-specific aspects

Advice on optimal cardiac target volume identification based on available evidence

Covers safety concerns and acute and long-term monitoring, including standardized reporting and follow-up

Lists areas of uncertainty requiring high-quality pre-clinical and clinical evidence before expanding STAR beyond scenarios where proven therapies are ineffective or unavailable